Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device

Daniel B. Sims, Gregg Rosner, Nir Uriel, José González-Costello, Frederick A. Ehlert, Ulrich P. Jorde

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Left ventricular assist device (LVAD) therapy improves survival and quality of life by mechanically unloading the left ventricle and maintaining hemodynamics in patients with end-stage heart failure. LVADs can also be lifesaving by maintaining hemodynamics during ventricular arrhythmia. Continuous-flow LVADs have become the preferred LVAD technology. As presented here, a continuous-flow LVAD successfully provided hemodynamic support to a patient in sustained ventricular fibrillation for over 12 hours when the internal defibrillator was unable to terminate the arrhythmia. This case demonstrates that continuous-flow LVADs can be lifesaving in the setting of otherwise certain hemodynamic collapse from sustained ventricular fibrillation. (PACE 2012; 35:e144-e148)

Original languageEnglish (US)
JournalPACE - Pacing and Clinical Electrophysiology
Volume35
Issue number5
DOIs
StatePublished - May 2012
Externally publishedYes

Fingerprint

Heart-Assist Devices
Ventricular Fibrillation
Hemodynamics
Cardiac Arrhythmias
Defibrillators
Heart Ventricles
Heart Failure
Quality of Life
Technology
Survival
Therapeutics

Keywords

  • chronic heart failure
  • left ventricular assist device
  • ventricular fibrillation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device. / Sims, Daniel B.; Rosner, Gregg; Uriel, Nir; González-Costello, José; Ehlert, Frederick A.; Jorde, Ulrich P.

In: PACE - Pacing and Clinical Electrophysiology, Vol. 35, No. 5, 05.2012.

Research output: Contribution to journalArticle

@article{17f93d8d267b468c82fa1dc4bd42cd98,
title = "Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device",
abstract = "Left ventricular assist device (LVAD) therapy improves survival and quality of life by mechanically unloading the left ventricle and maintaining hemodynamics in patients with end-stage heart failure. LVADs can also be lifesaving by maintaining hemodynamics during ventricular arrhythmia. Continuous-flow LVADs have become the preferred LVAD technology. As presented here, a continuous-flow LVAD successfully provided hemodynamic support to a patient in sustained ventricular fibrillation for over 12 hours when the internal defibrillator was unable to terminate the arrhythmia. This case demonstrates that continuous-flow LVADs can be lifesaving in the setting of otherwise certain hemodynamic collapse from sustained ventricular fibrillation. (PACE 2012; 35:e144-e148)",
keywords = "chronic heart failure, left ventricular assist device, ventricular fibrillation",
author = "Sims, {Daniel B.} and Gregg Rosner and Nir Uriel and Jos{\'e} Gonz{\'a}lez-Costello and Ehlert, {Frederick A.} and Jorde, {Ulrich P.}",
year = "2012",
month = "5",
doi = "10.1111/j.1540-8159.2011.03159.x",
language = "English (US)",
volume = "35",
journal = "PACE - Pacing and Clinical Electrophysiology",
issn = "0147-8389",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Twelve hours of sustained ventricular fibrillation supported by a continuous-flow left ventricular assist device

AU - Sims, Daniel B.

AU - Rosner, Gregg

AU - Uriel, Nir

AU - González-Costello, José

AU - Ehlert, Frederick A.

AU - Jorde, Ulrich P.

PY - 2012/5

Y1 - 2012/5

N2 - Left ventricular assist device (LVAD) therapy improves survival and quality of life by mechanically unloading the left ventricle and maintaining hemodynamics in patients with end-stage heart failure. LVADs can also be lifesaving by maintaining hemodynamics during ventricular arrhythmia. Continuous-flow LVADs have become the preferred LVAD technology. As presented here, a continuous-flow LVAD successfully provided hemodynamic support to a patient in sustained ventricular fibrillation for over 12 hours when the internal defibrillator was unable to terminate the arrhythmia. This case demonstrates that continuous-flow LVADs can be lifesaving in the setting of otherwise certain hemodynamic collapse from sustained ventricular fibrillation. (PACE 2012; 35:e144-e148)

AB - Left ventricular assist device (LVAD) therapy improves survival and quality of life by mechanically unloading the left ventricle and maintaining hemodynamics in patients with end-stage heart failure. LVADs can also be lifesaving by maintaining hemodynamics during ventricular arrhythmia. Continuous-flow LVADs have become the preferred LVAD technology. As presented here, a continuous-flow LVAD successfully provided hemodynamic support to a patient in sustained ventricular fibrillation for over 12 hours when the internal defibrillator was unable to terminate the arrhythmia. This case demonstrates that continuous-flow LVADs can be lifesaving in the setting of otherwise certain hemodynamic collapse from sustained ventricular fibrillation. (PACE 2012; 35:e144-e148)

KW - chronic heart failure

KW - left ventricular assist device

KW - ventricular fibrillation

UR - http://www.scopus.com/inward/record.url?scp=84860835093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860835093&partnerID=8YFLogxK

U2 - 10.1111/j.1540-8159.2011.03159.x

DO - 10.1111/j.1540-8159.2011.03159.x

M3 - Article

VL - 35

JO - PACE - Pacing and Clinical Electrophysiology

JF - PACE - Pacing and Clinical Electrophysiology

SN - 0147-8389

IS - 5

ER -